Vosbeck, K.; Förster, S.; Mayr, T.; Sahu, A.; Haddouti, E.-M.; Al-Adilee, O.; Körber, R.-M.; Bisht, S.; Muders, M.H.; Nesic, S.;
et al. Neuropilin2 in Mesenchymal Stromal Cells as a Potential Novel Therapeutic Target in Myelofibrosis. Cancers 2024, 16, 1924.
https://doi.org/10.3390/cancers16101924
AMA Style
Vosbeck K, Förster S, Mayr T, Sahu A, Haddouti E-M, Al-Adilee O, Körber R-M, Bisht S, Muders MH, Nesic S,
et al. Neuropilin2 in Mesenchymal Stromal Cells as a Potential Novel Therapeutic Target in Myelofibrosis. Cancers. 2024; 16(10):1924.
https://doi.org/10.3390/cancers16101924
Chicago/Turabian Style
Vosbeck, Karla, Sarah Förster, Thomas Mayr, Anshupa Sahu, El-Mustapha Haddouti, Osamah Al-Adilee, Ruth-Miriam Körber, Savita Bisht, Michael H. Muders, Svetozar Nesic,
and et al. 2024. "Neuropilin2 in Mesenchymal Stromal Cells as a Potential Novel Therapeutic Target in Myelofibrosis" Cancers 16, no. 10: 1924.
https://doi.org/10.3390/cancers16101924
APA Style
Vosbeck, K., Förster, S., Mayr, T., Sahu, A., Haddouti, E.-M., Al-Adilee, O., Körber, R.-M., Bisht, S., Muders, M. H., Nesic, S., Buness, A., Kristiansen, G., Schildberg, F. A., & Gütgemann, I.
(2024). Neuropilin2 in Mesenchymal Stromal Cells as a Potential Novel Therapeutic Target in Myelofibrosis. Cancers, 16(10), 1924.
https://doi.org/10.3390/cancers16101924